Skip to content
Screener

Utah Medical Products UTMD Q3 2025 earnings

Reported October 23, 2025 · Before market open

Revenue$9.8M
EPS$0.82

Next report

Oct 22, 2026 (In 1 week)

Financials

Q3 2025

Income statement

See full
Revenue$9.8M-1.9%
Gross profit$5.6M-3.4%
Operating income$2.6M-21.9%
Net income$2.6M-26.2%
EPS (diluted)$0.82-20.4%

Balance sheet

See full
Cash & equivalents$84.3M-4.7%
Total debt$241.0K-19.4%
Total equity$118.3M-4.8%
Total assets$122.0M-6.0%

Cash flow

See full
Operating cash flow$3.9M+0.6%
CapEx$27.0K-69.7%
Free cash flow$3.9M+2.2%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$201.86M-16.6%
Enterprise value$117.84M-23.5%
P/E17.4×+1.5×
P/S5.2×-0.3×

Profitability

See full
Gross margin57.1%-1.7pp
Operating margin30.8%-2.4pp
Net margin30.1%-4.5pp
FCF margin35.9%-2.4pp

Returns & leverage

See full
Return on equity9.6%-2.7pp
Debt / equity0×0.0×
Current ratio32.1×+2.5×

Segments

By product

See full
Gynecology/Electrosurgery/Urology$5.0M-2.7%
Neonatal$2.2M+27.0%
Blood Pressure Monitoring and Accessories$1.6M-23.4%
Obstetrics$1.0M-1.3%

By geography

See full
Global$9.6M-5.8%
Ous$3.9M-9.7%

FAQ

When did Utah Medical Products report Q3 2025 earnings?
Utah Medical Products (UTMD) reported Q3 2025 earnings on October 23, 2025 before market open.
What were Utah Medical Products's Q3 2025 revenue and EPS?
Utah Medical Products reported revenue of $9.8M and eps of $0.82 for Q3 2025.
How did Utah Medical Products's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 1.9% from $10.0M a year earlier and eps declined 19.6% from $1.02.
Where can I find Utah Medical Products's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001096906-25-001708) and the 10-Q periodic report (0001096906-25-001839) directly on SEC EDGAR. The filing index links above go to sec.gov.